Barton R W, Rothlein R, Ksiazek J, Kennedy C
Department of Immunology, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877.
J Immunol. 1989 Aug 15;143(4):1278-82.
The role of the CD18 complex of leukocyte glycoproteins in adhesion-dependent functions of human leukocytes in vitro has been well documented. A ligand, intercellular adhesion molecule-1 (ICAM-1), for at least one member of the CD18 complex has been identified. This molecule is inducible on many cell types including vascular endothelium and keratinocytes by inflammatory mediators such as IL-1, TNF, and IFN-gamma. ICAM-1 has been shown to mediate, in part, the in vitro adhesion of lymphocytes and neutrophils to endothelial cells expressing ICAM-1. In the present study we have shown that mAb's to the human CD18 complex and to human ICAM-1 cross react with rabbit cells and that both anti-CD18 and anti-CD11b but neither anti-CD11a nor anti-ICAM-1 mAb's inhibit neutrophil migration, an adhesion-dependent function, in vitro. Pretreatment of rabbits with anti-CD18 and anti-ICAM-1 but not anti-CD11a mAb inhibited by greater than 60% neutrophil migration into PMA-induced inflamed rabbit lungs. This effect of anti-ICAM-1 mAb on pulmonary neutrophil influx after PMA injection has important implications. Specifically, that ICAM-1 can function as a ligand for CD18 and can mediate, at least in part, the migration of neutrophils to inflammatory sites.
白细胞糖蛋白CD18复合物在人白细胞体外黏附依赖性功能中的作用已得到充分证明。已鉴定出CD18复合物至少一个成员的配体——细胞间黏附分子-1(ICAM-1)。该分子可被炎症介质如IL-1、TNF和IFN-γ诱导表达于包括血管内皮细胞和角质形成细胞在内的多种细胞类型上。已表明ICAM-1部分介导淋巴细胞和中性粒细胞与表达ICAM-1的内皮细胞的体外黏附。在本研究中,我们已表明针对人CD18复合物和人ICAM-1的单克隆抗体与兔细胞发生交叉反应,并且抗CD18和抗CD11b单克隆抗体而非抗CD11a和抗ICAM-1单克隆抗体在体外抑制中性粒细胞迁移(一种黏附依赖性功能)。用抗CD18和抗ICAM-1而非抗CD11a单克隆抗体预处理兔子,可抑制超过60%的中性粒细胞迁移到佛波酯诱导炎症的兔肺中。抗ICAM-1单克隆抗体对佛波酯注射后肺中性粒细胞流入的这种作用具有重要意义。具体而言,即ICAM-1可作为CD18的配体,并至少部分介导中性粒细胞向炎症部位的迁移。